New Test Reduces False Positive Results For HPV
3/22/2011
A new test for human papillomavirus (HPV) is just as sensitive as the old one, but more specific for detecting cervical cancer, meaning that it has fewer false positive results, according to a paper in the February 2011 Journal of Clinical Microbiology...
Although finding effective screening tools remains a priority, new treatment options for women with ovarian cancer, such as the ones outlined in the updated NCCN Guidelines for Ovarian Cancer, are vital to making steady progress against the disease according to Robert J. Morgan, MD, of City of Hope Comprehensive Cancer Center and chair of the NCCN Guidelines Panel for Ovarian Cancer. Dr...
Lack Of Appropriate Evidence Forces NICE To Turn Down Ovarian Cancer Drug In Draft Guidance
3/14/2011
In draft guidance issued last Friday NICE's expert independent advisory committee has not recommended trabectedin (Yondelis, PharmaMar) in combination with pegylated liposomal doxorubicin (PLDH) as a treatment for ovarian cancer because of concerns over how well it works compared with the most commonly-used treatments...
Fish Oil And Omega-3s, Helping Chemo Patients Gain Weight
3/01/2011
Fish oil has been found to be a successful supplement to your diet if undergoing the most popular form of treating cancer, chemotherapy. For years the oil has been studied for the treatment of clinical depression, anxiety, and enhancing the benefits from depression medications...
NICE Requests More Data To Help Appraise Maintenance Treatment For Follicular Non-Hodgkin's Lymphoma
3/01/2011
The National Institute for Health and Clinical Excellence (NICE) is currently appraising the use of rituximab (MabThera, Roche Products) as a first-line maintenance treatment[1] for patients with advanced follicular non-Hodgkin's lymphoma...
Researcher Instigates Cancer Cell Suicide
3/01/2011
A Wayne State University School of Medicine physician-researcher has developed a personalized therapy to treat a wide range of cancers. The treatment is based on a naturally occurring human enzyme that has been genetically modified to fool cancer cells into killing themselves...
Results from a study published in Blood, the Journal of the American Society of Hematology reveal a close relationship between pulmonary arterial hypertension (PAH)-exceedingly high blood pressure in the arteries carrying blood from the heart to the lungs-and abnormalities of the blood-forming cells in the bone marrow (known as myeloid abnormalities)...
Hope For Children Suffering From Fatal Brain Tumor
3/01/2011
A pediatric brain tumor that causes gruesome suffering is finally yielding its secrets. For the first time, scientists at the Stanford University School of Medicine have cultured human cells from this cancer, Diffuse Intrinsic Pontine Glioma, and used those cells to create an animal model of the disease...
Gene Test To Predict Nerve Damage From Bone Cancer Treatment
3/01/2011
Scientists have found a genetic test that predicts whether bone marrow cancer treatments including thalidomide are likely to give patients a debilitating side-effect. The study led by The Institute of Cancer Research (ICR) is published today in the Journal of Clinical Oncology...
Epeius Biotechnologies announced that the U.S. FDA has granted Phase 3 status for the Company's lead anti-cancer agent, Rexin-G, the first, and so far only, targeted gene delivery system developed to seek out and destroy metastatic cancer. According to Dr...